Our investors and other shareholders

Senexis is a privately held company funded by international and expert group of life science investors. Since its establishment, the Company has raised £6.3 million to build and develop a pipeline of drug candidates.

Current investors

BTG plc

BTG International Ltd  5 Fleet Place  London EC4M 7RD    UK

Tel.: +44 (0)20 7575 0000
Fax: +44 (0)20 7575 0010

The Wellcome Trust

Gibbs Building  215 Euston Road  London  NW1 2BE  UK

Tel.: +44 (0)20 7611 8888
Fax: +44 (0)20 7611 8545

---

Other shareholders include BioFocus plc, UMIST Ventures Limited (UVL), the Medical Research Council (MRC) & Peterhouse (the Cambridge College).

---

Management | Scientific Advisors | Collaborators